“Find your dose” and “increase if nothing happens” sound like sensible tuning. They are reasoning errors. A microdose is sub-perceptual by definition, so feeling nothing is the normal state, not a cue to escalate. [1] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706 Dose-response curves are not simply “more is better” — they can be flat, non-linear, or reversing — and the curve for any low-dose benefit has not been mapped. [2] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 Escalating until you feel something just walks you toward a different, perceptible dose: full-dose ≠ microdose. [3] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
Education-only methodology orientation. Not medical or dosing advice; no dose-adjustment guidance is given here.
How the field studies optimization — not instructions to optimize a practice. No dose, stack, schedule, cycling plan, titration method, tolerance-management strategy, or personal optimization protocol appears anywhere in this cluster.
”Feeling nothing” is the definition, not a failure
A microdose is characterised by being below the threshold of noticeable acute effect. So the absence of a felt experience is not a sign the dose is too small — it is the defining feature of the category. The instruction to increase until something is felt therefore does not optimize a microdose; it abandons it, pushing toward a perceptible or full dose with different pharmacology and different risk.
Dose-response is not a ladder
| Intuition | Reality |
|---|---|
| More dose, more benefit | Curves can be flat, inverted-U, or reversing |
| There is an “optimal dose” to find | No low-dose benefit curve has been established |
| Feeling more means working more | Perceptible effects indicate a different dose range |
| Scale down full-dose findings | A microdose is a distinct intervention |
The pharmacology literature treats dose-response as something to be measured, not assumed, because the relationship between dose and effect is frequently non-monotonic. [2] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 Importing a simple “higher is stronger” model is exactly the kind of unexamined intuition rigorous dose-finding exists to correct.
Why the full-dose comparison fails
Because a microdose is defined by sub-perceptibility, you cannot treat full-dose psychedelic effects as the upper end of a microdosing curve. They are a separate intervention with separate evidence. Using them to argue that “more would help” collapses the full-dose versus microdose distinction and quietly changes the subject.
What this means for “optimizing” a dose
If the baseline effect is unproven and the curve is unmapped, there is no defined target for personal dose-finding to reach. Home escalation also cannot separate any change from expectation, and raises exposure considerations that belong with a clinician. The methodological verdict: “find your dose” cannot deliver the knowledge it implies.
- Sub-perceptual by definition
- Feeling nothing is what a microdose is.
- Curves are not ladders
- Dose-response is often non-linear; more is not reliably better. [2] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478
- No mapped target
- No low-dose benefit curve has been established. [4] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831
- Don't scale full doses
- Full-dose ≠ microdose; the comparison changes the subject.
Frequently asked questions
If I feel nothing, shouldn't I just take more?
That instruction quietly redefines the practice. A microdose is sub-perceptual by definition, so feeling nothing is the expected condition, not a signal to escalate. Increasing until you feel something moves you toward a perceptible or full dose, which is a categorically different exposure with different effects and risks. Feeling nothing is not evidence the dose is too low; it is what a microdose is.
Doesn't a dose-response curve mean higher equals more benefit?
Not in general. Dose-response relationships are often non-linear, can be flat across a range, and can reverse, and the curve for a hypothetical low-dose benefit has not been established at all. Assuming more is better imports an intuition from simple drugs onto a setting where the relevant curve is unknown and the baseline effect is unproven.
Isn't full-dose research evidence that higher doses work?
Full-dose psychedelic research is about a different intervention. A microdose is defined precisely by being below the perceptual threshold, so findings from full doses cannot be scaled down to justify microdosing or to define an optimal low dose. Treating full-dose effects as the top of a microdosing dose-response curve collapses the full-dose versus microdose distinction.
So is there any safe way to find a better dose at home?
This site does not provide dose-adjustment guidance, and home titration cannot answer the question it poses because it has no control for expectation and no blinding. Escalation also raises exposure-related considerations that belong with a clinician and with the Safety cluster. The methodological answer is that personal dose-finding cannot establish what it claims to.